Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

Mar. 31, 2017

Payables and Accruals [Abstract]

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	March 31, 2017		December 31, 2016
Research costs - Nordic (1)	$	—	$	1,228
Research costs - other	10,057		8,404
Payroll and employee benefits	5,643		9,338
Professional fees	10,482		7,532
Other current liabilities	$	95	$	95
Total accrued expenses and other current liabilities	$	26,277	$	26,597

(1) Includes amounts accrued ratably over the estimated per patient treatment period in connection with services provided by Nordic Bioscience Clinical Development VII A/S on the Company's 24-month extension trial of TYMLOS.  Amounts do not include pass-through costs which are expensed as incurred or upon delivery.  See note 7 for additional information.